6EHV

scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.54 Å
  • R-Value Free: 0.314 
  • R-Value Work: 0.275 
  • R-Value Observed: 0.276 

wwPDB Validation   3D Report Full Report


This is version 1.1 of the entry. See complete history


Literature

scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery

Hargreaves, D.

To be published.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discoveryA [auth X]254Homo sapiensMutation(s): 0 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.54 Å
  • R-Value Free: 0.314 
  • R-Value Work: 0.275 
  • R-Value Observed: 0.276 
  • Space Group: I 41 2 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 132.899α = 90
b = 132.899β = 90
c = 80.746γ = 90
Software Package:
Software NamePurpose
BUSTERrefinement
XDSdata reduction
XDSdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2017-11-08
    Type: Initial release
  • Version 1.1: 2019-10-16
    Changes: Data collection